Fig. 2

Immuno-phenotyping profile of AML cases; (A) FSC and SSC, morphologic characteristic of blood cells; (B) myeloid leukemia positive for the MPO and CD13 markers (histograms display a single measurement parameter (Positive dataset)); (C) negative expression of acute lymphoblastic leukemia specific markers